Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Duodenoscope is commonly used to remove gallstones, heal pancreatitis, and drain bile ducts. This device is threaded through the mouth, throat, and stomach into top of the small intestine (duodenum). According to the U.S. FDA 2018 report, duodenoscopes are used in over 500,000 Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures, annually in the U.S. ERCP procedure combines Upper Gastrointestinal (GI) endoscopy and x-rays to treat bile and pancreatic duct problems.
The global duodenoscopes market size was valued at US$ 146.6 million in 2019 and is expected to witness a CAGR of 6.5% over the forecast period (2020 – 2027).
Figure 1: Global Duodenoscopes Market Share (%) Analysis in Terms of value, By Product Type, 2019
Increasing prevalence of gastrointestinal, liver, and pancreatic diseases is expected to drive the duodenoscopes market revenue
Increasing prevalence of gastrointestinal, liver, and pancreatic diseases is expected to increase demand for duodenoscopes during the forecast period. For instance, according to the Center for Disease Control and Prevention report published in 2017, the number of visits to emergency departments in the U.S. was approximately 8.3 million.
According to the Journal of Gastroenterology 2018 study, Gastrointestinal (GI), liver, and pancreatic diseases are highly prevalent, costly, and lead to substantial health care utilization in the U.S. In 2018, the total expenditure for GI diseases is approximately US$ 135.9 Bn in the U.S.
Duodenoscopes Market Restraints
Stringent government regulations for devices manufacturing and marketing and high chances of infection transmission are the major factors confining the use of duodenoscopes. In March 2018, the FDA issued warning letters to manufacturers of duodenoscopes in the U.S. including Fujifilm Medical Systems USA, Inc., Olympus Medical Systems Corporation, and Pentax of America, which failed to provide sufficient data to address postmarket surveillance studies requirements under Section 522 of the Federal Food, Drug, and Cosmetic Act.
Duodenoscopes Market - Regional Insights
On the basis of region, the global duodenoscopes market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America duodenoscopes market is expected to generate highest revenue share during the forecast period, owing to increasing cases of gastroenterology diseases coupled with increasing geriatric population in the region. According to the U.S Census Bureau 2014 report, around 1 in every 5 Americans will be 65 years or older by 2030.
Asia Pacific duodenoscopes market is expected to foresee highest growth rate, owing to increasing number of endoscopic procedures being conducted in the region coupled with an increasing prevalence of GI diseases among the regional population. Changing trends of lifestyle, low fiber diet, and increasing consumption of tobacco are the major causes of GI diseases in Asia Pacific. According to the WHO 2017 data, over 30% of smokers worldwide were from Asia Pacific, of which over 80% belonged to lower income groups in the region.
Figure 2: Global Duodenoscopes Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027
Duodenoscopes Market - Competitive Landscape
Key players operating in the global duodenoscopes market include, Custom Ultrasonics, Inc., ENDOMED, Fujifilm Holdings Corporation, Hoya Corporation, KARL STORZ GmbH & Co. KG., Olympus Corporation, PENTAX Medical Company, and SonoScape Medical Corp.